downgrad strictli due valuat
downgrad downgrad rate zoeti
neutral buy downgrad base strictli
valuat believ compani fundament
remain strong attract fact year
forecast zoeti livestock segment achiev highest
growth rate publicli trade compani
valuat howev zoeti close yesterday
trail oper ep next twelv month
oper ep estim street
consensu forward multipl three year
averag use price target
next page
maintain price target
 nyse
figur may add due round
com pani descript base parsippani new
jersey zoeti develop manufactur market
pharmaceut biolog livestock
companion anim compani also offer
diagnost product genom servic
servic custom primarili includ
livestock farmer veterinarian pet owner
compani product aid healthcar
cat dog equin swine beef dairi cattl
sheep poultri fish
note import disclosur page
note analyst certif page
determin price target took averag forward price-to-earnings seen sinc effici initi
announc incorpor dcf model recogn impress cash flow gener
appli multipl non-gaap ep estim deriv price target leav
wacc unchang util two-stag growth model free cash flow equiti
deriv price target use two-stag growth model due confid intermedi
outlook compani howev think would aggress use growth rate use
four year beyond estim perpetu thu second stage growth rate
assumpt much conserv due continu uncertainti regard precis
cash flow implic tax reform weight price-to-earnings methodolog heavili use
weight deriv price target
zoeti well diversifi term product custom base geographi compani industri
attract secular growth profil ca segment recession-resist opinion
howev compani livestock custom base subject commod cycl zoeti
limit histori publicli trade compani fairli lever final view compani
statu growth stock anoth risk consid given factor suitabl rate
depend livestock industri zoeti deriv signific amount revenu
custom associ agricultur industri subject mani factor beyond
control weather diseas outbreak
chang consum attitud companion anim busi depend consum
continu view pet member famili treat accordingli chang
attitud could halt human pet harm zoeti outlook addit lower
consumpt anim protein could hurt zoeti custom therebi reduc demand zoeti
competit anim health busi highli competit attract signific capit
new competitor innov new product solut competitor could displac zoeti
integr acquisit zoeti fairli acquisit throughout histori
anticip continu failur success integr acquisit could lead financi
result expect
failur and/or new product zoeti also intern develop new product product
line failur success develop sell new product could harm profit
legal product lawsuit common health care sector unfavor court decis could
hamper abil market product whether current patent zoeti success
challeng zoeti determin infring upon patent competitor
regulatori zoeti product must go variou regulatori agenc approv
companion anim market could undergo signific shift new regul
introduc regard veterinari prescript practic side busi
livestock industri also subject signific regulatori requir oversight
situat creat uncertainti zoeti custom
emerg market exposur zoeti deriv signific portion revenu
emerg market market tend riskier due polit econom and/or currenc
trade zoeti well-diversifi geograph term signific disrupt trade
trade polici could lead weaker-than-anticip result
addit inform avail upon request
kurt kemper herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
